Adam Kaplin

Adam Kaplin

Nessuna posizione attualmente
59 anni
Consumer Services
Health Technology
Health Services

Profilo

Adam Kaplin was the founder of MIRA Pharmaceuticals, Inc., founded in 2020, where the title held was President & Chief Science Officer from 2022 to 2024.
Dr. Kaplin is also the founder of Nousynapse Pharmaceuticals..
Dr. Kaplin is currently the Director-Johns Hopkins Ketamine Clinic at The Johns Hopkins University since 2002.
Dr. Kaplin is also currently the Director at Cody Unser First Step Foundation since 2005.
Formerly, Dr. Kaplin was Chief Scientific Officer at Q from 2020 to 2024.
Education includes a doctorate from The Johns Hopkins University conferred in 1996 and an undergraduate degree from Yale University conferred in 1988.

Posizioni attive di Adam Kaplin

SocietàPosizioneInizio
Corporate Officer/Principal 01/01/2002
Direttore/Membro del Consiglio 01/01/2005

Precedenti posizioni note di Adam Kaplin

SocietàPosizioneFine
Q/C TECHNOLOGIES, INC. Direttore Tecnico/Scientifico/R&S 15/04/2024
MIRA PHARMACEUTICALS, INC. Fondatore 07/03/2024
Vedi nel dettaglio l'esperienza di Adam Kaplin

Formazione di Adam Kaplin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

94

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private5

Consumer Services

Consumer Services

Health Technology

Health Services

Health Technology

  1. Mercati
  2. Insiders
  3. Adam Kaplin